All News


UK Chroma gets £30M for clinical trials

Chroma Therapeutics Ltd raised £30 million in a third private round, giving the chromatin specialist funding for the next three years and enabling it to advance the lead programme through Phase II clinical studies and bring two further products into the clinic.

Johnson and Johnson, RNID back UCL hearing research

Johnson & Johnson's Corporate Office of Science & Technology (COSAT) has agreed to fund a research programme on hearing loss conduced by University College London's (UCL) Ear Institute under a partnership between the pharmaceutical giant and RNID, a non-profit organisation for the hearing impaired in the UK.

Patent auction: many low bids, but some successes

Lots of buzz preceded what was billed as the world's first live, multi-lot technology patent auction on April 6, but reality failed to meet expectations for many of the inventors who put up 400-plus patents for sale.

Agency orders probe into clinical trials procedures

After finding nothing wrong with the specifics of the preclinical data, the product, or how the trial was conducted, the UK Medicines and Healthcare Products Regulatory Agency has ordered an investigation to changes in clinical trials procedures.

Biosensors defend the homeland

The DTI in the UK sent a Global Watch Mission team to California last year to look at biosensors and biosensing "major global industries, with the worldwide total annual sales of medical biosensors exceeding £2.8 billion in 2003". The team has just reported back.